Abstract: Infantile myofibromatosis is a mesenchymal disorder characterized by the fibrous proliferation of the skin, bone, muscle and viscera. It is the most common fibrous tumor in childhood. We present a newborn with skin and bone disease without visceral involvement, who showed good response to vinblastine and methotrexate. Clinical features, etiology, diagnosis, and treatment are reviewed.
INTRODUCTION
Infantile myofibromatosis (IM) is a mesenchymal disorder characterized by a fibrous proliferation of the skin, bone, muscle, and viscera. 1 Although rare, it is the most common fibrous tumor in childhood. 1, 2 Its name comes from the cells exhibiting distinct characteristics of fibroblasts and smooth muscle cells (myofibroblasts). 3 IM usually appears as firm nodules, with purplish or normal skin, located in the subcutaneous tissue. 2 It can be solitary or multiple. Most cases are limited to the skin, but systemic involvement has also been described. 4 The solitary type limited to the skin usually has a good prognosis with spontaneous regression. The visceral lesions are associated with high morbidity and mortality. 3 Most cases are sporadic.
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CASE REPORT
We present a male patient, full term, with no relevant medical history, which in the context of a routine hip x-ray control showed multiple osteolytic images in the sacrum and both femurs 
1,4
When located in the skin, IM is heterogeneous. It usually appears as a subcutaneous nodule, but can also appear as an ulcer, pedunculated lesion, or similar to a hemangioma, as in the case of our patient. The most common locations are the head, neck, and trunk, while the involvement of the limbs is rare.
5,6
The solitary form occurs predominantly in men and is typically seen in the dermis, subcutaneous tissues, and soft tissues; 50% of solitary forms and 90% of the multiple forms are congenital.
1,4
Bone involvement is rarely observed in the solitary form (5%), but it is common in the multicentric form (17-77%).
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The etiology of IM is still quite unknown. genesis (basic fibroblast growth factor -bFGF). 3, 8 Two patterns of inheritance -autosomal dominant and recessive -were described. 1, 3 The underlying mechanism of tumor regression and growth remains unknown, but it has been suggested to be related to angiogenic stimulation and regression, both triggered by bFGF. 3, 8 Urinary excretion of this factor increases in the active phase of the disease. 
1,10
Local complications are related to the mass effect and compression of the surrounding organs, such as the orbit, the larynx, the brachial plexus, and the vertebral cana. 2, 9 Bleeding from the tumor surface can be a fatal complication during the intrauterine period.
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There have also been reports associating IM with malformations. A probable role of bFGF in their appearance is therefore suggested. 8 The treatment of IM depends on its location. Although spontaneous regression often occurs, there have been reports of recurrence. 
